Topic: FDA & Drug Approvals
A summary of mainstream reporting, plus the facts and perspectives it leaves out. A more honest account of each story.
📔 Topics / FDA & Drug Approvals

FDA & Drug Approvals

1 Story
4 Related Topics
FDA Approves First Dual-Vector Gene Therapy For OTOF-Related Congenital Deafness
The FDA on April 23, 2026 approved the first dual-vector gene therapy for congenital deafness caused by OTOF mutations, authorizing Otarmeni (lunsotogene parvec-cwha) for pediatric and adult patients. Fox News